Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.511,17
-0,17%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cara Therapeutics Inc (CARA) Cara Therapeutics Inc (CARA) Notizie

Cara Therapeutics Inc

CARA
0,4636
0,0062 (1,36%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202422:06EDGAR2Form 425 - Prospectuses and communications, business..
20/12/202422:05EDGAR2Form 8-K/A - Current report: [Amend]
18/12/202423:10EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
18/12/202422:26EDGAR2Form S-4 - Registration of securities, business combinations
18/12/202413:25EDGAR2Form 425 - Prospectuses and communications, business..
18/12/202413:23EDGAR2Form 8-K - Current report
22/11/202422:09EDGAR2Form 8-K - Current report
06/11/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:21EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
14/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:15EDGAR2Form 8-K - Current report
11/7/202413:00GLOBECara Therapeutics Announces Exploration of Strategic..
08/7/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
18/6/202422:16EDGAR2Form 8-K - Current report
12/6/202423:12EDGAR2Form 8-K - Current report
12/6/202422:01GLOBECara Therapeutics Announces Outcome of Part A of KOURAGE-1..
07/6/202422:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/6/202422:05EDGAR2Form 8-K - Current report
06/6/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:10EDGAR2Form 8-K - Current report
13/5/202422:01GLOBECara Therapeutics Reports First Quarter 2024 Financial..
06/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202413:00GLOBECara Therapeutics to Announce First Quarter 2024 Financial..
02/4/202413:00GLOBECara Therapeutics to Present at the 23rd Annual Needham..
07/3/202413:00GLOBECara Therapeutics to Host Notalgia Paresthetica (NP) Virtual..
06/3/202422:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:10EDGAR2Form 8-K - Current report
04/3/202422:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
14/2/202400:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:01GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
05/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:59EDGAR2Form 8-K - Current report
22/1/202422:19EDGAR2Form 8-K - Current report
22/1/202413:00GLOBECara Therapeutics Prioritizes Late-Stage Notalgia..
Apertura: 0,4574 Min: 0,4105 Max: 0,4727
Chiusura: 0,4574

La tua Cronologia

NASDAQ
CARA
Cara Therapeutics
NASDAQ
REE
REE Automotive
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network